Clinical pregnancy in Turner syndrome following re-implantation of cryopreserved ovarian cortex

J Assist Reprod Genet. 2023 Oct;40(10):2385-2390. doi: 10.1007/s10815-023-02905-w. Epub 2023 Aug 11.

Abstract

Turner syndrome (TS) leads to a characteristic phenotype, including premature ovarian insufficiency and infertility. Ovarian tissue cryopreservation (OTC) is becoming an established fertility preservation strategy for both pre- and post-pubertal females and may offer the chance of having a biological family to selected patients with TS. To date, women with TS have had ovarian tissue cryopreserved but there are few reports of autologous re-implantation and none of pregnancy. We herein report, to our knowledge, the first clinical pregnancy in a patient with TS, conceived naturally following re-implantation of cryopreserved ovarian tissue which had been removed soon after spontaneous puberty. This provides proof of concept for OTC as a means of fertility preservation in TS.

Keywords: Fertility preservation; Ovarian cortex re-implantation; Premature ovarian insufficiency; Turner syndrome.

MeSH terms

  • Cryopreservation
  • Female
  • Fertility Preservation*
  • Humans
  • Pregnancy
  • Primary Ovarian Insufficiency* / etiology
  • Turner Syndrome* / genetics